Literature DB >> 21303477

The prevalence of rheumatoid factor isotypes and anti-cyclic citrullinated peptides in Malaysian rheumatoid arthritis patients.

Edmund Luke Gomez1, Suk Chyn Gun, Sushela Devi Somnath, Beryl D'Souza, Ai Lee Lim, Karuthan Chinna, Ammu K Radhakrishnan.   

Abstract

AIM: The purpose of this study is to compare the prevalence of rheumatoid factor (RF) isotypes and second generation anti-cyclic citrullinated peptides (anti-CCP) in Malaysian rheumatoid arthritis (RA) patients.
METHODS: In this cross-sectional study, 147 established RA patients from three ethnic groups were recruited from a major rheumatology clinic in Malaysia. Enzyme-linked immunosorbent assays (ELISA) for serum RF isotypes IgA, IgG and IgM as well as second-generation anti-CCP were performed and the prevalence of each auto-antibody was compared in the three ethnic groups.
RESULTS: The anti-CCP was the most prevalent auto-antibody in each of the ethnic groups, followed closely by RF IgM and RF IgG. Rheumatoid factor IgA was the least prevalent across all three ethnic groups. The anti-CCP-RF IgM combination provided the best test sensitivity. Seroprevalence of anti-CCP was strongly associated with the presence of each of the RF isotypes. The seroprevalence of RF and anti-CCP did not increase or decrease with advancing age, age at onset and disease duration.
CONCLUSION: When used alone, anti-CCP provides a diagnostic advantage over RF IgM on the basis of test sensitivity. Considering the high cost of the anti-CCP assay, step-wise serum testing with IgM RF followed by anti-CCP may provide a more economically sensible option to optimize test sensitivity for RA.
© 2010 The Authors. International Journal of Rheumatic Diseases © 2010 Asia Pacific League of Associations for Rheumatology and Blackwell Publishing Asia Pty Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21303477     DOI: 10.1111/j.1756-185X.2010.01573.x

Source DB:  PubMed          Journal:  Int J Rheum Dis        ISSN: 1756-1841            Impact factor:   2.454


  4 in total

1.  Correlation of Demographic and Clinical Characteristics with Rheumatoid Factor Seropositivity in Rheumatoid Arthritis Patients.

Authors:  Maizatul Akmal Othman; Wan Syamimee Wan Ghazali; Nurul Khaiza Yahya; Kah Keng Wong
Journal:  Malays J Med Sci       Date:  2016-12-07

2.  Anti-cyclic citrullinated peptide antibody is a good indicator for the diagnosis of rheumatoid arthritis.

Authors:  Asrul Abdul Wahab; Marlyn Mohammad; M M Rahman; Mohd Shahrir Mohamed Said
Journal:  Pak J Med Sci       Date:  2013-05       Impact factor: 1.088

3.  Anti-Cyclic Citrullinated Peptide Antibody and Periodontal Status in Rheumatoid Arthritis Patients.

Authors:  Wan Majdiah Wan Mohamad; Soh Ke Jia; Wan Syamimee Wan Ghazali; Haslina Taib
Journal:  Pak J Med Sci       Date:  2018 Jul-Aug       Impact factor: 1.088

4.  Anti-carbamylated protein antibodies in rheumatoid arthritis patients and their association with rheumatoid factor.

Authors:  Maizatul A Othman; Wan Syamimee W Ghazali; Wan Zuraida W A Hamid; Kah K Wong; Nurul K Yahya
Journal:  Saudi Med J       Date:  2017-09       Impact factor: 1.484

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.